Three Different Cannabinoid-Based Medicines Approved by the FDA

The U.S. Food and Drug Administration (FDA) is aware that cannabis and cannabis-derived products are being used for a number of medical conditions, such as AIDS wasting syndrome, epilepsy, neuropathic pain, treatment of spasticity associated with multiple sclerosis, and cancer and chemotherapy-induced nausea. Despite this fact, the FDA has not yet approved a marketing application for a drug product containing or derived from the whole cannabis plant. It has, however, approved three cannabinoid-based medicines derived from isolated synthetics: Marinol, Syndros, and Cesamet. Marinol...

(c) Medical Jane- Read full news story here.

Receive Updates

No spam guarantee.

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to toolbar